AL
CALA

Airain Ltd’s Calithera Biosciences, Inc CALA Stock Holding History

Airain Ltd’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-888
Closed -$96K – 1110
2015
Q3 		$96K Buy
+888
New +$115K 0.01% 774

Other funds holding CALA

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MMPI
Morgenthaler Management Partners IX Portola Valley, California $22.6M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Airain Ltd's CALA Position: Q4 2015 in Review

Airain Ltd sold out of Calithera Biosciences, Inc (CALA) in Q4 2015, closing a stake of 888 shares — an estimated $96K sold.

Airain Ltd first reported a position in CALA in Q3 2015 and held it in 1 quarter. The position peaked at $96K in Q3 2015. 54 funds tracked by Wall St. Rank hold CALA as of Q4 2015.

  • Airain Ltd reported no remaining Calithera Biosciences, Inc position as of Q4 2015 after selling out during the quarter.
  • Airain Ltd sold 888 Calithera Biosciences, Inc shares in Q4 2015, an estimated $96K.
  • Airain Ltd first reported a position in Calithera Biosciences, Inc in Q3 2015 and held it in 1 quarter.
  • Airain Ltd's Calithera Biosciences, Inc position peaked at $96K in Q3 2015.
  • 54 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2015.

Based on Airain Ltd's 13F filing for Q4 2015, filed 11 Feb 2016.